Brief: Mabion Signs Deal With Swiss-Based Adolf Kühner
30/11/2021 14:40
Nov 30 (Reuters) - Mabion SA MABP.WA :
* SIGNS DEAL WITH SWISS-BASED ADOLF KÜHNER AG
* UNDER DEAL, ADOLF KUHNER AG TO DELIVER 4 BIOREACTORS
* TOTAL NET DEAL VALUE AT EUR 2.3 MILLION
Source text for Eikon: ID:nEM4GmSnNa
Further company coverage: MABP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects